Sign in

CIK 0001710072

  • Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821725586
Phone
+1 720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
  1. 4 Other disposition Director disposed of 3,473,543 shares (other)
  2. 4 Exercise or conversion General Counsel acquired 5,400 shares (option exercise)
  3. 4 Exercise or conversion General Counsel acquired 5,400 shares (option exercise)
  4. 4 Exercise or conversion Chief Scientific Officer acquired 172,585 shares (option exercise)
  5. 4 Open-market sale Chief Scientific Officer sold 479 shares at an average $19.11 ($9,155)
  6. 4 Open-market sale Chief Scientific Officer sold 69,740 shares at an average $19.91 ($1,388,788)
  7. 4 Open-market sale Chief Scientific Officer sold 29,451 shares at an average $19.82 ($583,823)
  8. 4 Open-market sale Chief Scientific Officer sold 44,172 shares at an average $17.88 ($789,909)
  9. 4 Open-market sale Chief Scientific Officer sold 7,182 shares at an average $18.17 ($130,483)
  10. 4 Open-market sale Chief Scientific Officer sold 1,270 shares at $18.02 ($22,885)
  11. 4 Open-market sale Chief Scientific Officer sold 21,028 shares at an average $18.39 ($386,743)
  12. 4 Open-market sale Chief Scientific Officer sold 5,778 shares at an average $18.24 ($105,409)
  13. 4 Open-market sale Chief Scientific Officer sold 26,454 shares at an average $17.10 ($452,483)
  14. 4 Open-market sale Chief Scientific Officer sold 58,546 shares at an average $18.30 ($1,071,422)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 11 · 203 filings